ArticleSensors (Basel, Switzerland)2026
Experimental Validation of a Compact and Versatile Bioimpedance Measurement Platform Based on the SENSIPLUS Chip.
Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The growing demand for wearable and Internet of Medical Things (IoMT) devices is driving the development of compact, low-power platforms for continuous physiological monitoring. Bioimpedance analysis represents a versatile non-invasive technique for the assessment of tissue properties, body composition, and respiratory dynamics. This work presents a comprehensive experimental validation of a compact bioimpedance measurement platform based on the SENSIPLUS chip, a CMOS sensor interface integrating a frequency-programmable lock-in amplifier for Electrochemical Impedance Spectroscopy in the 10 kHz-1 MHz range. The platform was validated at three complementary levels: (i) electrical characterization on Debye tissue-equivalent circuits using a three-point bilinear calibration, with analysis of the electrode-skin contribution and repeatability assessment; (ii) in vivo multi-frequency bioimpedance spectroscopy (BIS) with Cole-Cole model fitting and hook-effect correction; and (iii) single-frequency thoracic impedance plethysmography for respiratory monitoring. Results were compared against an Agilent E4980A precision Inductance (L), Capacitance (C), and Resistance (R) meter and a calibrated spirometer. The presented device achieved a maximum resistance error below 5.7% and reactance deviation under 6 Ω across the investigated frequency range, Cole-Cole parameters consistent with reference values, and strong linear correlation (R2=0.97) between thoracic impedance variations and tidal volume, with respiratory rate estimation errors below 2% across the ten sessions, specifically 1.43% during normal breathing and 1.96% during deep breathing. These results demonstrate that the SENSIPLUS-based platform achieves metrological performance compatible with the requirements of wearable IoMT applications, here demonstrated in a single-subject proof-of-concept study, while relying for all critical analog functions on a compact (1.5×1.5) mm
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.